排序方式： 共有25条查询结果，搜索用时 0 毫秒
1.
The marketing literature exhibits a consistent lack of concern to recognize the distinct differences among the various possible manifestations of compulsiveness in the consumer-marketplace domain. The practice of using terms pertaining to different manifestations of compulsiveness synonymously, especially when the meaning of the term “compulsive behavior” is itself under debate, creates further semantic uncertainties that hinder typological endeavors in the budding area of abnormal or deviant consumer behavior. This article attempts to remove such uncertainties by elucidating and establishing the differences among the above manifestations. 相似文献
2.
3.
4.
Since the onset of Sarbanes‐Oxley and other new compliance regulations, global businesses have faced a bewildering tide of new regulations. What you don't know can—and will—hurt you. So, how can you stay ahead of the curve? © 2008 Wiley Periodicals, Inc. 相似文献
5.
David Horn Debra Goff Nikhil Khandelwal James Spalding Nkechi Azie Fei Shi 《Journal of medical economics》2016,19(7):728-734
Objective: In the phase III SECURE trial, isavuconazole was non-inferior to voriconazole for all-cause mortality for the primary treatment of invasive mold disease (IMD) caused by Aspergillus spp. and other filamentous fungi. This analysis assessed whether hospital resource utilization was different between patients treated with isavuconazole vs voriconazole in SECURE. Methods: The analysis population comprised adults with proven/probable/possible IMD enrolled in SECURE. The primary endpoint was hospital length of stay (LOS) in the overall trial population. Patients were also stratified by estimated glomerular filtration rate-modification of diet in renal disease category (< 60?mL/min/1.73 m2 [moderate-to-severe impairment] and ≥60?mL/min/1.73 m2 [mild or no impairment]), body mass index (BMI; <25, ≥25–<30, and ≥30?kg/m2), and age (≤45, >45–≤65, and >65 years). Results: Data from 516 patients (258 per arm) were evaluated. Overall, median LOS was not statistically significantly different between the isavuconazole (15.0 days) and voriconazole (16.0 days; p?=?0.607) arms. Median LOS was statistically significantly shorter in patients with moderate-to-severe renal impairment treated with isavuconazole (9.0 days) vs voriconazole (19.0 days; hazard ratio [HR]: 3.44; 95% confidence interval [CI]?=?1.51–7.83). Median LOS was shorter, but not significantly, in patients with a BMI ≥30?kg/m2 (isavuconazole 13.5 days vs voriconazole 22 days; HR?=?1.57; 95% CI?=?0.70–3.52) or aged >65 years (isavuconazole 15.0 days vs voriconazole 20.0 days; HR?=?1.37; 95% CI?=?0.87–2.16). Limitations: As the patient subgroups analyzed were small, sub-group findings should be interpreted with caution in light of the lack of statistical significance for each sub-group-by-treatment interaction. Conclusions: Isavuconazole may reduce hospital LOS in certain subgroups of patients with IMD, especially those with moderate-to-severe renal impairment. 相似文献
6.
7.
Delbert C. Goff 《Journal of Economics and Finance》1994,18(3):287-299
Numerous studies document stock return anomalies as they relate to firm size, earnings-price ratios, and share price. The
causes of these anomalies have not been adequately explained. This study provides additional information in this area by examining
the relationships among the anomalies for NASDAQ traded stocks and those for NYSE and AMEX stocks. The results suggest that
the relationships among the anomalies are not constant across the two groups of stocks. The anomalies are different for NASDAQ
stocks than for NYSE and AMEX stocks. 相似文献
8.
9.
Most analyses of the film market treat it as a single entity where producers make films based on average consumer interest while critics serve as forecasters or signalers of film quality to these consumers. We describe the film market as two‐sided—a mass market (average consumer) side and a high quality/artistic (cineaste) side—that each influence film maker production decisions and critical reviews as critics balance the preferences of mass market consumers and their own more artistic inclination. Using 1,824 films released during 2000–2014, we examine determinants of box office revenues and critical reviews, while addressing the overlap between them. Our results indicate that consumers and critics respond differently not only to film rating but also to film budgets, story sources, genre, and political content. We then use the dichotomy between average and high quality, artistic film consumers as a basis for understanding the normative views of the film markets relative to other two‐sided markets as well as the political economy of film regulation. (JEL C30, D10, Z11) 相似文献
10.
Sandra H. Goff John Ifcher Homa Zarghamee Alex Reents Patrick Wade 《Contemporary economic policy》2023,41(2):243-261
We study the COVID-19 pandemic's effect on government and market attitudes using within-subject comparisons of survey responses elicited before and after the onset of the pandemic. We find that participants develop significantly less favorable opinions toward government and markets; and that participants increase support for bigger government significantly and for redistribution, in general, marginally significantly. There is no evidence this leads to an increase in support for specific redistributive policies, nor for government to play a larger role in specific functions. Our results echo the stubbornness of American preferences for redistribution and suggest the presence of a principle-implementation gap. 相似文献